Evolution of Biologics Screening Technologies

By Cariuk Peter   Gardener Matthew J.   Vaughan Tristan J.  

Pharmaceuticals, Vol. 6, Iss. 5, 2013-05 ,pp. : 681-688

MDPI

Access to resources Recommend Favorite

Formulation Patents and Dermatology and Obviousness

By Mei Dan-Feng   Liu Josephine   Davitz Michael A.  

Pharmaceutics, Vol. 3, Iss. 4, 2011-11 ,pp. : 914-922

MDPI

Access to resources Recommend Favorite

Biosimilars: Company Strategies to Capture Value from the Biologics Market

By Calo-Fernández Bruno   Martínez-Hurtado Juan Leonardo  

Pharmaceuticals, Vol. 5, Iss. 12, 2012-12 ,pp. : 1393-1408

MDPI

Access to resources Recommend Favorite

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

By Fiandaca Massimo S.   Bankiewicz Krystof S.   Federoff Howard J.  

Pharmaceuticals, Vol. 5, Iss. 6, 2012-06 ,pp. : 553-590

MDPI

Access to resources Recommend Favorite

Facilitating a More Efficient Commercial Review Process for Pediatric Drugs and Biologics

By Rykhus Ryan D.   Shepard Zachary V.   Young Alix   Frisby Hadley   Calder Kailee A.   Coon Collin M.   Falk Justin A.   McAndrews Sydney R.   Turner Aspen   Chang Christina   Michelsohn Johanna   Petch Raegan   Dieker Sarah M.   Markworth Benjamin H.   Alamo-Perez Kevin   Hosack Aaron J.   Berg Jacob M.   Schmidt Christian   Storsberg Joachim   Brown Mark A.  

Diseases, Vol. 6, Iss. 1, 0201-12 ,pp. : 2-2

MDPI

Access to resources Recommend Favorite